Second-generation pterocarpanquinones: synthesis and antileishmanial activity
VS Faiões, LCRM Frota, EF Cunha-Junior… - Journal of Venomous …, 2018 - SciELO Brasil
Background: Despite the development of new therapies for leishmaniasis, among the 200
countries or territories reporting to the WHO, 87 were identified as endemic for Tegumentary …
countries or territories reporting to the WHO, 87 were identified as endemic for Tegumentary …
Flavonoids as Inspiration for the Design and Synthesis of New Antiproliferative, Antiparasitic and Antiviral Compounds: An Account
GS Caleffi, AJM Silva, CD Netto… - Journal of the Brazilian …, 2024 - SciELO Brasil
Modified flavonoids of the sub-group of pterocarpans, 5-carba-pterocarpans, 5-
carbapterocarpens, 1-carba-isoflavanones, coumestans, and aurones were synthesized and …
carbapterocarpens, 1-carba-isoflavanones, coumestans, and aurones were synthesized and …
Reactive oxygen species release, alkylating ability, and DNA interactions of a pterocarpanquinone: A test case for electrochemistry
TL Silva, FR Ferreira, CC de Vasconcelos… - …, 2016 - Wiley Online Library
The electrochemistry of a redox‐based bioactive pterocarpanquinone, designated as LQB‐
118, and its precursor chromenquinone (CQ) was investigated in protic and aprotic media …
118, and its precursor chromenquinone (CQ) was investigated in protic and aprotic media …
LQB-118 compound inhibits migration and induces cell death in glioblastoma cells
PS Bernardo, GHC Guimaraes… - Oncology …, 2020 - spandidos-publications.com
Glioblastoma (GBM) is the most frequent malignant brain tumor. It represents the most
aggressive astrocytoma with an overall survival of 14 months. Despite improvements in …
aggressive astrocytoma with an overall survival of 14 months. Despite improvements in …
Design, synthesis, and antitumor evaluation of novel anthraquinone derivatives
LA Oliveira, HD Nicolella, RA Furtado, NM Lima… - Medicinal Chemistry …, 2020 - Springer
N-alkylated and O-alkylated anthraquinone derivatives with structures analogous to
mitoxantrone were synthesized, characterized, and evaluated for their cytotoxic properties …
mitoxantrone were synthesized, characterized, and evaluated for their cytotoxic properties …
Preparative chiral separation and absolute configuration of the synthetic pterocarpanquinone LQB‐118
GS Scatena, NM Cassiano, CD Netto, PRR Costa… - Chirality, 2017 - Wiley Online Library
The racemic pterocarpanquinone LQB‐118 is active, in mice and hamsters, against
tegumentary and visceral leishmaniasis. This compound also presents antiinflammatory and …
tegumentary and visceral leishmaniasis. This compound also presents antiinflammatory and …
LQB-118 Suppresses Migration and Invasion of Prostate Cancer Cells by Modulating the Akt/GSK3β Pathway and MMP-9/Reck Gene Expression
T Martino, GF De Bem, SVM Santos… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Prostate cancer (PCa) is one of the most common malignancies in adult
men. LQB-118 is a pterocarpanquinone with antitumor activity toward prostate cancer cells …
men. LQB-118 is a pterocarpanquinone with antitumor activity toward prostate cancer cells …
[HTML][HTML] The pterocarpanquinone LQB 118 inhibits inflammation triggered by zymosan in vivo and in vitro
É de Almeida Lima, LHA Cavalcante-Silva… - International …, 2020 - Elsevier
LQB 118, a hydride molecule, has been described as an antineoplastic and antiparasitic
drug. Recently, LQB118 was also shown to display anti-inflammatory properties using an …
drug. Recently, LQB118 was also shown to display anti-inflammatory properties using an …
Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias
VM Rumjanek, RC Maia, EJ Salustiano… - Anti-Cancer Agents in …, 2019 - ingentaconnect.com
In an attempt to find anticancer agents that could overcome multidrug resistance (MDR), two
new classes of modified isoflavonoids were designed and synthesized, and their …
new classes of modified isoflavonoids were designed and synthesized, and their …